Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Current Assets: 2020-2025

Historic Current Assets for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $224.0 million.

  • Xeris Biopharma Holdings' Current Assets rose 37.60% to $224.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year increase of 37.60%. This contributed to the annual value of $167.7 million for FY2024, which is 7.29% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Current Assets is $224.0 million, which was up 20.71% from $185.6 million recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Current Assets ranged from a high of $224.0 million in Q3 2025 and a low of $124.4 million during Q3 2021.
  • In the last 3 years, Xeris Biopharma Holdings' Current Assets had a median value of $165.5 million in 2023 and averaged $171.2 million.
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Current Assets decreased by 16.35% in 2023, and later surged by 37.60% in 2025.
  • Xeris Biopharma Holdings' Current Assets (Quarterly) stood at $142.6 million in 2021, then soared by 31.01% to $186.8 million in 2022, then declined by 16.35% to $156.3 million in 2023, then climbed by 7.29% to $167.7 million in 2024, then surged by 37.60% to $224.0 million in 2025.
  • Its Current Assets was $224.0 million in Q3 2025, compared to $185.6 million in Q2 2025 and $163.5 million in Q1 2025.